Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring Impact Factor, Indexing, Ranking 2024

Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access journal that concentrates on the discovery, development, and validation of assays, instruments, and technologies with the potential to facilitate accurate detection of dementia in its various forms and stages. Of particular interest are promising dementia biomarkers, ranging from gene expression and proteomic markers, to imaging, cognitive and functional markers of disease progression or treatment response. Review our Author Guidelines and submit your manuscript to DADM.

《阿尔茨海默病与痴呆：诊断、评估与疾病监测》（Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 简称 DADM）是一本开放获取期刊，专注于发现、开发和验证那些有可能促进痴呆症多种形式和各个阶段准确检测的检测方法、仪器和技术。特别关注的是具有潜力的痴呆生物标志物，这些标志物涵盖了从基因表达和蛋白质组标志物，到疾病进展或治疗反应的成像、认知和功能标志物。请查阅我们的《作者指南》并提交您的稿件至 DADM。